Rule 8.3 - SKYEPHARMA PLC
Rule 8.3 announcements issued between 9 and 18 November 2005 inclusive showed
incorrect Long and Short Relevant Securities positions as Stock Borrowing and
Lending figures had been incorrectly included in the totals.
FORM 8.3
DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE
(Rule 8.3 of the City Code on Takeovers and Mergers)
1. KEY INFORMATION
Name of person dealing (Note 1) BARCLAYS PLC
Company dealt in SKYEPHARMA PLC
Class of relevant security to which the GBP 0.10
dealings being disclosed relate (Note 2)
Date of dealing 18 NOVEMBER 2005
2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
(1) Relevant securities 15,581,372 (2.07%) 2,133,098 (0.28%)
(2) Derivatives (other than options) 2,585,944 (0.34%) 8,859,101 (1.18%)
(3) Options and agreements to
purchase/sell
Total 18,167,316 (2.41%) 10,992,199 (1.46%)
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to
purchase/sell
Total
(c) Rights to subscribe (Note 3)
Class of relevant security: Details
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of securities Price per unit (Note 5)
Purchase 25,391 0.5103
Purchase 287,982 0.5108
Purchase 85,910 0.5118
Purchase 7,403 0.5126
Purchase 431,973 0.5189
Purchase 26,250 0.5228
Sale 5,040 0.5097
(b) Derivatives transactions (other than options)
Product name, Long/short (Note 6) Number of securities (Note 7) Price per unit (Note 5)
e.g. CFD
CFD Long 5,040 0.5097
CFD Short 5,041 0.51026
CFD Short 85,910 0.5118
CFD Short 7,403 0.5126
CFD Long 120,956 0.5109
CFD Long 38,042 0.5109
CFD Long 155,092 0.5109
CFD Long 85,910 0.5108
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name, Writing, Number of Exercise Type, e.g. Expiry Option money
e.g. call option selling, securities to price American, date paid/received
purchasing, which the option European per unit (Note
varying etc. relates (Note 7) etc. 5)
(ii) Exercising
Product name, e.g. call option Number of securities Exercise price per unit (Note 5)
(d) Other dealings (including new securities) (Note 4)
Nature of transaction (Note 8) Details Price per unit (if applicable)
(Note 5)
4. OTHER INFORMATIONS
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other
person relating to the voting rights of any relevant securities under any option referred to on this
form or relating to the voting rights or future acquisition or disposal of any relevant securities to
which any derivative referred to on this form is referenced. If none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure 21 NOVEMBER 2005
Contact name BARCLAYS CORPORATE SECRETARIAT
Telephone number 020 7116 2913
If a connected EFM, name of offeree/offeror with which
connected
If a connected EFM, state nature of connection (Note 10)
Notes
The Notes on Form 8.3 can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk